SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Colfax Corp – ‘8-K’ for 3/16/21

On:  Friday, 3/19/21, at 5:08pm ET   ·   For:  3/16/21   ·   Accession #:  1193125-21-87685   ·   File #:  1-34045

Previous ‘8-K’:  ‘8-K’ on / for 3/11/21   ·   Next & Latest:  ‘8-K’ on / for 4/29/21

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/19/21  Colfax Corp                       8-K:1,9     3/16/21   13:446K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 2: EX-1.1      Underwriting Agreement                              HTML    160K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     14K 
 9: R1          Document and Entity Information                     HTML     52K 
11: XML         IDEA XML File -- Filing Summary                      XML     13K 
 8: XML         XBRL Instance -- d345371d8k_htm                      XML     18K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.DEF  XBRL Definitions -- cfx-20210316_def                 XML     41K 
 6: EX-101.LAB  XBRL Labels -- cfx-20210316_lab                      XML     68K 
 7: EX-101.PRE  XBRL Presentations -- cfx-20210316_pre               XML     43K 
 4: EX-101.SCH  XBRL Schema -- cfx-20210316                          XSD     15K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
13: ZIP         XBRL Zipped Folder -- 0001193125-21-087685-xbrl      Zip     52K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i Colfax CORP  i false  i 0001420800 0001420800 2021-03-16 2021-03-16 0001420800 us-gaap:CommonStockMember 2021-03-16 2021-03-16 0001420800 us-gaap:CapitalUnitsMember 2021-03-16 2021-03-16

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i March 16, 2021

 

 

Colfax Corporation

(Exact name of registrant as specified in its charter)

 

 

 

 i Delaware    i 001-34045    i 54-1887631

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 i 420 National Business Parkway,  i 5th Floor

 i Annapolis Junction,  i MD  i 20701

(Address of principal executive offices) (Zip Code)

 i (301)  i 323-9000

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

 i Common Stock, par value $0.001 per share    i CFX    i New York Stock Exchange
 i 5.75% Tangible Equity Units    i CFXA    i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

On March 19, 2021, Colfax Corporation (the “Company”) issued and sold 16,100,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), including 2,100,000 shares of Common Stock issued pursuant to the exercise in full by the Underwriters (as defined below) of their option to purchase additional shares of Common Stock, in a registered public offering pursuant to its Registration Statement on Form S-3 (File No. 333-253236) filed under the Securities Act of 1933, as amended, which Registration Statement became automatically effective upon filing on February 18, 2021. The Shares were sold pursuant to an Underwriting Agreement, dated March 16, 2021 (the Underwriting Agreement), among the Company and Goldman Sachs & Co. LLC and Evercore Group L.L.C., as representatives of the several underwriters named in Schedule 1 thereto (the “Underwriters”). The Company estimates that it will receive net proceeds from the offering of approximately $711.3 million, after deducting underwriting discounts and commissions and estimated expenses payable by the Company.

The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by the full text of the Underwriting Agreement, a copy of which is filed herewith as Exhibit 1.1 and is incorporated by reference herein. A copy of the opinion of Latham & Watkins LLP relating to the legality of the issuance and sale of the Shares is filed herewith as Exhibit 5.1 and is incorporated by reference herein.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit
Number

  

Description

  1.1    Underwriting Agreement, dated March 16, 2021, among Colfax Corporation, Goldman Sachs & Co. LLC and Evercore Group L.L.C.
  5.1    Opinion of Latham & Watkins LLP.
23.1    Consent of Latham & Watkins LLP (included in Exhibit 5.1).
104    Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 19, 2021

 

COLFAX CORPORATION
By:  

/s/ Christopher M. Hix

Name:   Christopher M. Hix
Title:   Executive Vice President, Finance,
  Chief Financial Officer
  (Principal Financial Officer)

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:3/19/21
For Period end:3/16/21
2/18/2110-K,  424B7,  8-K,  S-3ASR
 List all Filings 
Top
Filing Submission 0001193125-21-087685   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 13, 5:30:48.2am ET